Home > Cashflow Statement > AARTI DRUGS

AARTI DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

AARTI DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-82 Cr₹-136 Cr₹17 Cr₹92 Cr₹-81 Cr

What is the latest Cash Flow from Financing Activities ratio of AARTI DRUGS ?

The latest Cash Flow from Financing Activities ratio of AARTI DRUGS is ₹-82 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-82 Cr
Mar2024₹-136 Cr
Mar2023₹17 Cr
Mar2022₹92 Cr
Mar2021₹-81 Cr

How is Cash Flow from Financing Activities of AARTI DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-82 Cr
Negative
Mar2024 ₹-136 Cr
Negative
Mar2023 ₹17 Cr
-82.02
Mar2022 ₹92 Cr
Positive
Mar2021 ₹-81 Cr -

Compare Cash Flow from Financing Activities of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹3,393.2 Cr -0.7% 0.3% -3.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,613.0 Cr 0.9% 6.2% 0.6% Stock Analytics
DIVIS LABORATORIES ₹167,105.0 Cr 1.8% 4.8% 6.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹145,926.0 Cr 1.3% 9.8% 37.7% Stock Analytics
DR REDDYS LABORATORIES ₹109,088.0 Cr 1.7% 5.8% 6.7% Stock Analytics
CIPLA ₹107,120.0 Cr -1.3% 0.9% -8.9% Stock Analytics


AARTI DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-0.7%

0.3%

-3.8%

SENSEX

0%

1.2%

9.7%


You may also like the below Video Courses